Search Results

Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial

Authors: Van Gaal, L. F.; Caterson, I. D.; Coutinho, W.; Finer, N.; Maggioni, A. P.; Sharma, A. M.; Torp-Pedersen, C.; Ge, H.; Moran, S. A.; Shepherd, G. M.; James, W. P. T.

Source: Diabetes, Obesity and Metabolism, Volume 12, Number 1, January 2010 , pp. 26-34(9)

Publisher: Blackwell Publishing

Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study

Authors: Viner, Russell M.; Hsia, Yingfen; Neubert, Antje; Wong, Ian C. K.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 6, December 2009 , pp. 844-851(8)

Publisher: Blackwell Publishing

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

Authors: Heal, David J.; Gosden, Jane; Smith, Sharon L.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 6, December 2009 , pp. 861-874(14)

Publisher: Blackwell Publishing

Editorial [Hot Topic: The Medicinal Chemistry of New Agents to Treat Obesity (Guest Editor: Jinhwa Lee)]

Author: Lee, Jinhwa

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 465-465(1)

Publisher: Bentham Science Publishers

Promising Strategies for Obesity Pharmacotherapy: Melanocortin-4 (MC- 4) Receptor Agonists and Melanin Concentrating Hormone (MCH) Receptor-1 Antagonists

Authors: Jeon, Moon-Kook; Cheon, Hyae G.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 504-538(35)

Publisher: Bentham Science Publishers

New Trends in Medicinal Chemistry Approaches to Antiobesity Therapy

Authors: Lee, Jinhwa; Song, Kwang-Seop; Kang, Jahyo; Lee, Suk H.; Lee, Junwon

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 6, April 2009 , pp. 564-596(33)

Publisher: Bentham Science Publishers

Effect of antiobesity medications in patients with type 2 diabetes mellitus

Authors: Choussein, Souzana; Makri, Angeliki A.; Frangos, Constantinos C.; Petridou, Eleni Th.; Daskalopoulou, Stella S.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 7, July 2009 , pp. 641-664(24)

Publisher: Blackwell Publishing

Combination pharmaceutical therapies for obesity

Authors: Gadde, Kishore M; Allison, David B

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 6, April 2009 , pp. 921-925(5)

Publisher: Informa Healthcare

Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)

Authors: Sharma; Caterson; Coutinho; Finer; Van Gaal,; Maggioni; Torp-Pedersen; Bacher; Shepherd; James

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 3, March 2009 , pp. 239-250(12)

Publisher: Blackwell Publishing

Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract

Authors: Filippatos, T. D.; Mikhailidis, D. P.

Source: Current Pharmaceutical Design, Volume 15, Number 5, February 2009 , pp. 490-516(27)

Publisher: Bentham Science Publishers

Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity

Authors: Supuran, Claudiu T; Fiore, Anna Di; Simone, Giuseppina De

Source: Expert Opinion on Emerging Drugs, Volume 13, Number 2, June 2008 , pp. 383-392(10)

Publisher: Informa Healthcare

Reproductive Endocrinology and Clinical Aspects of Obesity in Women

Authors: Metwally, Mostafa; Ledger, William L.; Li, Tin Chiu

Source: Annals of the New York Academy of Sciences, Volume 1127, Number 1, April 2008 , pp. 140-146(7)

Publisher: Blackwell Publishing

Editorial [ Carbonic Anhydrases as Drug Targets Executive Editor: Claudiu T. Supuran ]

Author: Supuran, Claudiu T.

Source: Current Pharmaceutical Design, Volume 14, Number 7, March 2008 , pp. 601-602(2)

Publisher: Bentham Science Publishers

Carbonic Anhydrases - An Overview

Author: Supuran, Claudiu T.

Source: Current Pharmaceutical Design, Volume 14, Number 7, March 2008 , pp. 603-614(12)

Publisher: Bentham Science Publishers

Are Carbonic Anhydrase Inhibitors Suitable for Obtaining Antiobesity Drugs ?

Authors: Simone, Giuseppina D.; Fiore, Anna D.i.; Supuran, Claudiu T.

Source: Current Pharmaceutical Design, Volume 14, Number 7, March 2008 , pp. 655-660(6)

Publisher: Bentham Science Publishers

Benefits and risks of antiobesity drugs weighed up

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 21-21(1)

Publisher: Adis International

Prevention of Type 2 diabetes: fact or fiction?

Author: Chiasson, Jean-Louis

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 18, December 2007 , pp. 3147-3158(12)

Publisher: Informa Healthcare

An Analysis of Vigimed, a Global E-Mail System for the Exchange of Pharmacovigilance Information

Authors: Johansson, Kristina; Olsson, Sten; Hellman, Björn; Meyboom, Ronald H.B.

Source: Drug Safety, Volume 30, Number 10, 2007 , pp. 883-889(7)

Publisher: Adis International

Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)

Authors: Poonam Mishra,; Zobair M. Younossi,

Source: Current Drug Discovery Technologies, Volume 4, Number 2, August 2007 , pp. 133-140(8)

Publisher: Bentham Science Publishers

Quantitative image analysis in adipose tissue using an automated image analysis system: Differential effects of peroxisome proliferator-activated receptor-α and -γ agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice

Authors: Okamoto, Yuji; Higashiyama, Hiroyuki; Inoue, Hiroki; Kanematsu, Masahiro; Kinoshita, Mine; Asano, Satoshi

Source: Pathology International, Volume 57, Number 6, June 2007 , pp. 369-377(9)

Publisher: Blackwell Publishing